-
1
-
-
51649093834
-
Recent advances in head and neck cancer
-
Haddad RI and Shin DM: Recent advances in head and neck cancer. N Engl J Med 359: 1143-1154, 2008.
-
(2008)
N Engl J Med
, vol.359
, pp. 1143-1154
-
-
Haddad, R.I.1
Shin, D.M.2
-
2
-
-
0037208591
-
An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer
-
Adelstein DJ, Li Y, Adams GL, et al: An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21: 92-98, 2003.
-
(2003)
J Clin Oncol
, vol.21
, pp. 92-98
-
-
Adelstein, D.J.1
Li, Y.2
Adams, G.L.3
-
3
-
-
73249143536
-
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
-
Bonner JA, Harari PM, Giralt J, et al: Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 11: 21-28, 2010.
-
(2010)
Lancet Oncol
, vol.11
, pp. 21-28
-
-
Bonner, J.A.1
Harari, P.M.2
Giralt, J.3
-
4
-
-
0345714860
-
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer
-
DOI 10.1056/NEJMoa031317
-
Forastiere AA, Goepfert H, Maor M, et al: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349: 2091-2098, 2003. (Pubitemid 37464533)
-
(2003)
New England Journal of Medicine
, vol.349
, Issue.22
, pp. 2091-2098
-
-
Forastiere, A.A.1
Goepfert, H.2
Maor, M.3
Pajak, T.F.4
Weber, R.5
Morrison, W.6
Glisson, B.7
Trotti, A.8
Ridge, J.A.9
Chao, C.10
Peters, G.11
Lee, D.-J.12
Leaf, A.13
Ensley, J.14
Cooper, J.15
-
5
-
-
4344639820
-
Preliminary results of Radiation Therapy Oncology Group 97-03: A randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck
-
DOI 10.1200/JCO.2004.12.012
-
Garden AS, Harris J, Vokes EE, et al: Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J Clin Oncol 22: 2856-2864, 2004. (Pubitemid 41079904)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.14
, pp. 2856-2864
-
-
Garden, A.S.1
Harris, J.2
Vokes, E.E.3
Forastiere, A.A.4
Ridge, J.A.5
Jones, C.6
Horwitz, E.M.7
Glisson, B.S.8
Nabell, L.9
Cooper, J.S.10
Demas, W.11
Gore, E.12
-
6
-
-
4444346176
-
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: A 9-year, 337-patient, multi-institutional experience
-
DOI 10.1093/annonc/mdh308
-
Brockstein B, Haraf DJ, Rademaker AW, et al: Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol 15: 1179-1186, 2004. (Pubitemid 39199304)
-
(2004)
Annals of Oncology
, vol.15
, Issue.8
, pp. 1179-1186
-
-
Brockstein, B.1
Haraf, D.J.2
Rademaker, A.W.3
Kies, M.S.4
Stenson, K.M.5
Rosen, F.6
Mittal, B.B.7
Pelzer, H.8
Fung, B.B.9
Witt, M.-E.10
Wenig, B.11
Portugal, L.12
Weichselbaum, R.W.13
Vokes, E.E.14
-
7
-
-
35548972994
-
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
-
DOI 10.1056/NEJMoa070956
-
Posner MR, Hershock DM, Blajman CR, et al: Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357: 1705-1715, 2007. (Pubitemid 350005152)
-
(2007)
New England Journal of Medicine
, vol.357
, Issue.17
, pp. 1705-1715
-
-
Posner, M.R.1
Hershock, D.M.2
Blajman, C.R.3
Mickiewicz, E.4
Winquist, E.5
Gorbounova, V.6
Tjulandin, S.7
Shin, D.M.8
Cullen, K.9
Ervin, T.J.10
Murphy, B.A.11
Raez, L.E.12
Cohen, R.B.13
Spaulding, M.14
Tishler, R.B.15
Roth, B.16
Viroglio, R.D.C.17
Venkatesan, V.18
Romanov, I.19
Agarwala, S.20
Harter, K.W.21
Dugan, M.22
Cmelak, A.23
Markoe, A.M.24
Read, P.W.25
Steinbrenner, L.26
Colevas, A.D.27
Norris Jr., C.M.28
Haddad, R.I.29
more..
-
8
-
-
32144433159
-
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
-
DOI 10.1056/NEJMoa053422
-
Bonner JA, Harari PM, Giralt J, et al: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354: 567-578, 2006. (Pubitemid 43209104)
-
(2006)
New England Journal of Medicine
, vol.354
, Issue.6
, pp. 567-578
-
-
Bonner, J.A.1
Harari, P.M.2
Giralt, J.3
Azarnia, N.4
Shin, D.M.5
Cohen, R.B.6
Jones, C.U.7
Sur, R.8
Raben, D.9
Jassem, J.10
Ove, R.11
Kies, M.S.12
Baselga, J.13
Youssoufian, H.14
Amellal, N.15
Rowinsky, E.K.16
Ang, K.K.17
-
9
-
-
79952012758
-
Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: A phase II clinical study
-
Merlano M, Russi E, Benasso M, et al: Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study. Ann Oncol 22: 712-717, 2010.
-
(2010)
Ann Oncol
, vol.22
, pp. 712-717
-
-
Merlano, M.1
Russi, E.2
Benasso, M.3
-
10
-
-
33644971314
-
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: A pilot phase II study of a new combined-modality paradigm
-
DOI 10.1200/JCO.2004.00.1792
-
Pfister DG, Su YB, Kraus DH, et al: Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. J Clin Oncol 24: 1072-1078, 2006. (Pubitemid 46638804)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.7
, pp. 1072-1078
-
-
Pfister, D.G.1
Su, Y.B.2
Kraus, D.H.3
Wolden, S.L.4
Lis, E.5
Aliff, T.B.6
Zahalsky, A.J.7
Lake, S.8
Needle, M.N.9
Shaha, A.R.10
Shah, J.P.11
Zelefsky, M.J.12
-
11
-
-
77954737028
-
Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer
-
Cohen EE, Haraf DJ, Kunnavakkam R, et al: Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 28: 3336-3343, 2010.
-
(2010)
J Clin Oncol
, vol.28
, pp. 3336-3343
-
-
Cohen, E.E.1
Haraf, D.J.2
Kunnavakkam, R.3
-
12
-
-
61449122062
-
Phase I study of lapatinib in combination with chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck
-
Harrington KJ, El-Hariry IA, Holford CS, et al: Phase I study of lapatinib in combination with chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck. J Clin Oncol 27: 1100-1107, 2009.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1100-1107
-
-
Harrington, K.J.1
El-Hariry, I.A.2
Holford, C.S.3
-
13
-
-
78650968294
-
Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer
-
Kao J, Genden EM, Gupta V, et al: Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer. Cancer 117: 318-326, 2011.
-
(2011)
Cancer
, vol.117
, pp. 318-326
-
-
Kao, J.1
Genden, E.M.2
Gupta, V.3
-
14
-
-
0037674062
-
Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck
-
DOI 10.1200/JCO.2003.10.051
-
Cohen EE, Rosen F, Stadler WM, et al: Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 21: 1980-1987, 2003. (Pubitemid 46606387)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.10
, pp. 1980-1987
-
-
Cohen, E.E.W.1
Rosen, F.2
Stadler, W.M.3
Recant, W.4
Stenson, K.5
Huo, D.6
Vokes, E.E.7
-
15
-
-
77950332087
-
Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab?
-
Eriksen JG, Lassen P and Overgaard J: Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab? Lancet Oncol 11: 312-313, 2010.
-
(2010)
Lancet Oncol
, vol.11
, pp. 312-313
-
-
Eriksen, J.G.1
Lassen, P.2
Overgaard, J.3
-
16
-
-
13944263935
-
Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systemic review
-
DOI 10.1158/1055-9965.EPI-04-0551
-
Kreimer AR, Clifford GM, Boyle P, et al: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14: 467-475, 2005. (Pubitemid 40270113)
-
(2005)
Cancer Epidemiology Biomarkers and Prevention
, vol.14
, Issue.2
, pp. 467-475
-
-
Kreimer, A.R.1
Clifford, G.M.2
Boyle, P.3
Franceschi, S.4
-
17
-
-
34247379040
-
Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: Implications for clinical research in head and neck cancers
-
Gillison ML: Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers. J Clin Oncol 24: 5623-5625, 2006.
-
(2006)
J Clin Oncol
, vol.24
, pp. 5623-5625
-
-
Gillison, M.L.1
-
18
-
-
74949100842
-
Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma
-
Shi W, Kato H, Perez-Ordonez B, et al: Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol 27: 6213-6221, 2009.
-
(2009)
J Clin Oncol
, vol.27
, pp. 6213-6221
-
-
Shi, W.1
Kato, H.2
Perez-Ordonez, B.3
-
19
-
-
74549123751
-
HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer
-
Lassen P, Eriksen JG, Hamilton-Dutoit S, et al: HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer. Radiother Oncol 94: 30-35, 2010.
-
(2010)
Radiother Oncol
, vol.94
, pp. 30-35
-
-
Lassen, P.1
Eriksen, J.G.2
Hamilton-Dutoit, S.3
-
20
-
-
33644849030
-
Molecular classification identifies a subset of human papillomavirus- associated oropharyngeal cancers with favorable prognosis
-
DOI 10.1200/JCO.2004.00.3335
-
Weinberger PM, Yu Z, Haffty BG, et al: Molecular classification identifies a subset of human papillomavirus - associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 24: 736-747, 2006. (Pubitemid 46622040)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.5
, pp. 736-747
-
-
Weinberger, P.M.1
Yu, Z.2
Haffty, B.G.3
Kowalski, D.4
Harigopal, M.5
Brandsma, J.6
Sasaki, C.7
Joe, J.8
Camp, R.L.9
Rimm, D.L.10
Psyrri, A.11
-
21
-
-
70349275952
-
The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer
-
Kao J, Vu HL, Genden EM, et al: The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer. Cancer 115: 4586-4594, 2009.
-
(2009)
Cancer
, vol.115
, pp. 4586-4594
-
-
Kao, J.1
Vu, H.L.2
Genden, E.M.3
-
22
-
-
63149095503
-
Surrogate endpoints for overall survival in locally advanced head and neck cancer: Meta-analyses of individual patient data
-
Michiels S, Le Maitre A, Buyse M, et al: Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data. Lancet Oncol 10: 341-350, 2009.
-
(2009)
Lancet Oncol
, vol.10
, pp. 341-350
-
-
Michiels, S.1
Le Maitre, A.2
Buyse, M.3
-
23
-
-
0346103804
-
Induction Chemotherapy followed by Concomitant TFHX Chemoradiotherapy with Reduced Dose Radiation in Advanced Head and Neck Cancer
-
Haraf DJ, Rosen FR, Stenson K, et al: Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer. Clin Cancer Res 9: 5936-5943, 2003. (Pubitemid 38018079)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.16 I
, pp. 5936-5943
-
-
Haraf, D.J.1
Rosen, F.R.2
Stenson, K.3
Argiris, A.4
Mittal, B.B.5
Witt, M.E.6
Brockstein, B.E.7
List, M.A.8
Portugal, L.9
Pelzer, H.10
Weichselbaum, R.R.11
Vokes, E.E.12
-
24
-
-
0037440070
-
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: Curative and organ-preserving therapy for advanced head and neck cancer
-
DOI 10.1200/JCO.2003.06.006
-
Vokes EE, Stenson K, Rosen FR, et al: Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 21: 320-326, 2003. (Pubitemid 46606162)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.2
, pp. 320-326
-
-
Vokes, E.E.1
Stenson, K.2
Rosen, F.R.3
Kies, M.S.4
Rademaker, A.W.5
Witt, M.E.6
Brockstein, B.E.7
List, M.A.8
Fung, B.B.9
Portugal, L.10
Mittal, B.B.11
Pelzer, H.12
Weichselbaum, R.R.13
Haraf, D.J.14
-
25
-
-
77954190940
-
Human papillomavirus and survival of patients with oropharyngeal cancer
-
Ang KK, Harris J, Wheeler R, et al: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363: 24-35, 2010.
-
(2010)
N Engl J Med
, vol.363
, pp. 24-35
-
-
Ang, K.K.1
Harris, J.2
Wheeler, R.3
-
26
-
-
0032543663
-
Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
-
DOI 10.1056/NEJM199806183382503
-
Brizel DM, Albers ME, Fisher SR, et al: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338: 1798-1804, 1998. (Pubitemid 28277960)
-
(1998)
New England Journal of Medicine
, vol.338
, Issue.25
, pp. 1798-1804
-
-
Brizel, D.M.1
Albers, M.E.2
Fisher, S.R.3
Scher, R.L.4
Richtsmeier, W.J.5
Hars, V.6
George, S.L.7
Huang, A.T.8
Prosnitz, L.R.9
-
27
-
-
73949129781
-
Predictors of competing mortality in advanced head and neck cancer
-
Mell LK, Dignam JJ, Salama JK, et al: Predictors of competing mortality in advanced head and neck cancer. J Clin Oncol 28: 15-20, 2010.
-
(2010)
J Clin Oncol
, vol.28
, pp. 15-20
-
-
Mell, L.K.1
Dignam, J.J.2
Salama, J.K.3
-
28
-
-
33646851264
-
Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: Preliminary experience and future directions
-
Milano MT, Vokes EE, Kao J, et al: Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions. Int J Oncol 28: 1141-1151, 2006.
-
(2006)
Int J Oncol
, vol.28
, pp. 1141-1151
-
-
Milano, M.T.1
Vokes, E.E.2
Kao, J.3
-
29
-
-
53049103005
-
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: A multi-institutional phase II trial investigating three radiotherapy dose levels
-
Salama JK, Stenson KM, Kistner EO, et al: Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels. Ann Oncol 19: 1787-1794, 2008.
-
(2008)
Ann Oncol
, vol.19
, pp. 1787-1794
-
-
Salama, J.K.1
Stenson, K.M.2
Kistner, E.O.3
-
30
-
-
39649109915
-
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial
-
DOI 10.1093/jnci/djn011
-
Fakhry C, Westra WH, Li S, et al: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100: 261-269, 2008. (Pubitemid 351480538)
-
(2008)
Journal of the National Cancer Institute
, vol.100
, Issue.4
, pp. 261-269
-
-
Fakhry, C.1
Westra, W.H.2
Li, S.3
Cmelak, A.4
Ridge, J.A.5
Pinto, H.6
Forastiere, A.7
Gillison, M.L.8
-
31
-
-
34247331367
-
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma
-
DOI 10.1200/JCO.2005.04.6136
-
Licitra L, Perrone F, Bossi P, et al: High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 24: 5630-5636, 2006. (Pubitemid 46631302)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.36
, pp. 5630-5636
-
-
Licitra, L.1
Perrone, F.2
Bossi, P.3
Suardi, S.4
Mariani, L.5
Artusi, R.6
Oggionni, M.7
Rossini, C.8
Cantu, G.9
Squadrelli, M.10
Quattrone, P.11
Locati, L.D.12
Bergamini, C.13
Olmi, P.14
Pierotti, M.A.15
Pilotti, S.16
-
32
-
-
33846264909
-
Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation
-
DOI 10.1016/j.ijrobp.2006.09.044, PII S036030160603224X
-
Milas L, Fang FM, Mason KA, et al: Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation. Int J Radiat Oncol Biol Phys 67: 568-572, 2007. (Pubitemid 46108328)
-
(2007)
International Journal of Radiation Oncology Biology Physics
, vol.67
, Issue.2
, pp. 568-572
-
-
Milas, L.1
Fang, F.-M.2
Mason, K.A.3
Valdecanas, D.4
Hunter, N.5
Koto, M.6
Ang, K.K.7
|